TeamDrive
RUS

The Ministry of Health of the Russian Federation improves patent protection law

18 September 2018

GMP News

The Ministry of Health of Russia has published a notification on the development of amendments to Federal Law No. 61 of 12.04.2010 “On circulation of medicinal products”, designed to synchronize it with regulatory acts of the Eurasian Economic Union.

The procedure for registration of the medicinal product will be corrected.

According to information published on the state web portal for draft normative and legal acts, pursuant to Article 7 of the Agreement on Uniform Principles and Rules for the circulation of medicinal products within the Eurasian Economic Union, the Rules for Registration and Expert Examination of Medicinal Products for Human Use have been approved. The Rules require submission of information on the existence of intellectual rights to a medicinal product protected by patents in force in the territory of a member state of the Eurasian Economic Union, when registering medicinal products.

Therefore, the Ministry of Health of the Russian Federation proposes amendments to the Federal Law “On circulation of medicinal products”, requiring that for the state registration of medicinal products for human use, the applicant should submit information on the existing protection of intellectual property rights for the claimed medicinal product, and also confirming that the registration of the medicinal product does not violate the rights of third parties to intellectual property.

Source


Previous publication Next publication

Media Center

  • 31 October 2018

    Scientists unveiled a more effective approach for assessing drug response

    Scientists from Eli Lilly and Company, the Icahn School of Medicine at Mount Sinai (New York, USA) and Sema4 (Stamford, USA) released results from a proof-of-concept study demonstrating that patient-derived cells offer a more effective approach for assessing drug response than conventional methods.

  • 30 October 2018

    Researchers developed an AI approach to identify antibiotic resistance genes

    Researchers at the University of California San Diego (USA) have developed an approach that uses machine learning to identify and predict which genes make infectious bacteria resistant to antibiotics. The approach was tested on strains of Mycobacterium tuberculosis – the bacteria that cause tuberculosis (TB) in humans. It identified 33 known and 24 new antibiotic resistance genes in these bacteria.

  • 29 October 2018

    Expanding the reach of gene editing with a new CRISPR enzyme

    The CRISPR-Cas9 gene editing system has been widely studied because of its potential therapeutic applications, but limitations in the number of locations on the genome it can target remain a major drawback. Now scientists at the Massachusetts Institute of Technology have identified a new Cas9 enzyme that they say can help CRISPR reach more gene mutations.

  • 26 October 2018

    Biotech Backed by Bain, Pfizer loads prime CNS assets into new biotech

    Pfizer has followed through on its pledge to divest a hunk of its neuroscience R&D, spinning several programs into a new company called Cerevel Therapeutics backed by $350 million in venture funding. Pfizer is contributing a trio of clinical-stage drug candidates—including a Parkinson’s therapy due to start phase 3 testing next year—plus a clutch of earlier-stage programs, while Bain Capital and affiliates stumped up the initial funding.

Read more